Longevica hires drug-approval veteran as CEO
Fresh off the world’s largest mammalian longevity screen, Longevica names ex-Genentech exec Prasun Mishra to steer science toward the clinic. Longevica Therapeutics has spent the past four years and $13 million running mice through their entire lives to find drugs that might extend ours. Now, with t
<p>Fresh off the world’s largest mammalian longevity screen, Longevica names ex-Genentech exec Prasun Mishra to steer science toward the clinic. Longevica Therapeutics has spent the past four years and $13 million running mice through their entire lives to find drugs that might extend ours. Now, with t</p>